Related Experiment Video
Updated: Jun 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A
Yung-Chia Chen1, Wen-Chi Su, Jing-Ying Huang
1Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 112, Taiwan.
Abstract:
Hepatitis C virus (HCV) replication involves many viral and host factors. Here, we employed a lentivirus-based RNA interference (RNAi) screening approach to search for possible cellular factors. By using a kinase-phosphatase RNAi library and an HCV replicon reporter system, we identified a serine-threonine kinase, Polo-like kinase 1 (Plk1), as a potential host factor regulating HCV replication. Knockdown of Plk1 reduced both HCV RNA replication and nonstructural (NS) protein production in both HCV replicon cells and HCV-infected cells while it did not significantly affect host cellular growth or cell cycle. Overexpression of Plk1 in the knockdown cells rescued HCV replication. Interestingly, the ratio between the hyperphosphorylated form (p58) and the basal phosphorylated form (p56) of NS5A was lower in the Plk1 knockdown cells and Plk1 kinase inhibitor-treated cells than in the control groups. Further studies showed that Plk1 could be immunoprecipitated together with NS5A. Both proteins partially colocalized in the perinuclear region. Furthermore, Plk1 could phosphorylate NS5A to both the p58 and p56 forms in an in vitro assay system; the phosphorylation efficiency was comparable to that of the reported casein kinase. Taken together, this study shows that Plk1 is an NS5A phosphokinase and thereby indirectly regulates HCV RNA replication. Because of the differential effects of Plk1 on HCV replication and host cell growth, Plk1 could potentially serve as a target for anti-HCV therapy.
Insights
Polo-like kinase 1 (Plk1) was identified as a host factor that regulates Hepatitis C virus (HCV) replication. Plk1 directly phosphorylates the viral NS5A protein, making it a potential therapeutic target for HCV infection.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Hepatitis C virus (HCV) replication depends on numerous viral and host factors.
- Identifying host factors is crucial for understanding viral replication and developing therapies.
Purpose of the Study:
- To identify cellular factors that regulate HCV replication using a large-scale RNA interference screen.
- To investigate the role of Polo-like kinase 1 (Plk1) in HCV replication.
Main Methods:
- Utilized a lentivirus-based RNA interference (RNAi) screening approach with a kinase-phosphatase library.
- Employed an HCV replicon reporter system to monitor viral replication.
- Performed knockdown and overexpression studies of Plk1 in HCV-infected cells and replicon cells.
Main Results:
- Knockdown of Plk1 significantly reduced HCV RNA replication and nonstructural protein production without affecting host cell growth.
- Plk1 was found to directly phosphorylate the HCV NS5A protein, influencing its phosphorylation state (p58 and p56 forms).
- Plk1 and NS5A were shown to interact and partially colocalize within cells.
Conclusions:
- Polo-like kinase 1 (Plk1) acts as an NS5A phosphokinase, indirectly regulating HCV RNA replication.
- Plk1's specific role in HCV replication, independent of host cell cycle, suggests it as a promising therapeutic target for anti-HCV strategies.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release
Viruses with RNA Genomes
Leaky Scanning

